12 results
DEF 14A
PROK
ProKidney Corp - Ordinary Shares
26 May 23
Definitive proxy
8:00am
transition period.
Board Diversity
The following matrix provides the diversity statistics for the Board.
Board Diversity Matrix (As of March 31, 2023 … and experience, independence, knowledge of our industry, possible conflicts of interest, diversity, the extent to which the candidate would fill a present need
424B3
PROK
ProKidney Corp - Ordinary Shares
21 Apr 23
Prospectus supplement
4:18pm
, or other “pivotal study” of a new drug to support marketing authorization, to submit a diversity action plan for such clinical trial. The action plan … must include the sponsor’s diversity goals for enrollment, as well as a rationale for the goals and a description of how the sponsor will meet them
POS AM
PROK
ProKidney Corp - Ordinary Shares
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
a diversity action plan for such clinical trial. The action plan must include the sponsor’s diversity goals for enrollment, as well as a rationale … for the goals and a description of how the sponsor will meet them. A sponsor must submit a diversity action plan to FDA by the time the sponsor submits
10-K
ol95cm1v8v5ifc7014o
23 Mar 22
Annual report
5:32pm
DEFA14A
0eaxgcscvyds91
18 Jan 22
Additional proxy soliciting materials
5:15pm
424B4
vlpxqax
1 Jul 21
Prospectus supplement with pricing info
5:20pm
S-1/A
v7k500xoz9fy22jxnk1k
9 Jun 21
IPO registration (amended)
6:15am
S-1
51k9w tlik
2 Jun 21
IPO registration
5:17pm
DRS
3e3zc8
21 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next